These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9247727)

  • 1. Simple test to evaluate the risk of urinary calcium stone formation.
    Grases F; García-Ferragut L; Costa-Bauzá A; Conte A; García-Raja A
    Clin Chim Acta; 1997 Jul; 263(1):43-55. PubMed ID: 9247727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.
    Ryall RL
    World J Urol; 1997; 15(3):155-64. PubMed ID: 9228722
    [No Abstract]   [Full Text] [Related]  

  • 5. Circadian variations in the risk of urinary calcium oxalate stone formation.
    Robert M; Roux JO; Bourelly F; Boularan AM; Guiter J; Monnier L
    Br J Urol; 1994 Sep; 74(3):294-7. PubMed ID: 7953257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urolithiasis, inhibitors and promoters.
    Grases F; Conte A
    Urol Res; 1992; 20(1):86-8. PubMed ID: 1736493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new procedure to evaluate the inhibitory capacity of calcium oxalate crystallization in whole urine.
    Grases F; García-Ferragut L; Costa-Bauzá A
    Int Urol Nephrol; 1995; 27(6):653-61. PubMed ID: 8725028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children.
    Rodriguez A; Saez-Torres C; Mir C; Casasayas P; Rodriguez N; Rodrigo D; Frontera G; Buades JM; Gomez C; Costa-Bauza A; Grases F
    BMC Urol; 2018 Dec; 18(1):116. PubMed ID: 30567525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dual effect of urinary macromolecules on the crystallization of calcium oxalate endogenous in urine.
    Gohel MD; Shum DK; Li MK
    Urol Res; 1992; 20(1):13-7. PubMed ID: 1736481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of calcium oxalate crystallization in urine.
    Tiselius HG; Fornander AM; Nilsson MA
    Urol Res; 1987; 15(2):83-6. PubMed ID: 3590434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of spontaneous crystalluria in patients with calcium oxalate calculi].
    Nguyen HV; Daudon M; Réveillaud RJ; Jungers P
    Nephrologie; 1987; 8(2):65-9. PubMed ID: 3614507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic calcium oxalate urinary lithiasis: usefulness of Parks' and Tiselius' indices in the evaluation of the risk of stone formation.
    Robert M; Roux JO; Boularan AM; Bourelly F; Monnier L; Grasset D
    Urol Int; 1995; 55(2):88-92. PubMed ID: 8533202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation.
    Drach GW; Thorson S; Randolph A
    Trans Am Assoc Genitourin Surg; 1979; 71():62-6. PubMed ID: 161827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation.
    Drach GW; Thorson S; Randolph A
    J Urol; 1980 Apr; 123(4):519-23. PubMed ID: 7365890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.